Your browser doesn't support javascript.
loading
Adipose Tissue Distribution and Survival Among Women with Nonmetastatic Breast Cancer.
Bradshaw, Patrick T; Cespedes Feliciano, Elizabeth M; Prado, Carla M; Alexeeff, Stacey; Albers, Kathleen B; Chen, Wendy Y; Caan, Bette J.
Afiliação
  • Bradshaw PT; Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, California, USA.
  • Cespedes Feliciano EM; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Prado CM; Department of Agricultural, Food, and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Alexeeff S; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Albers KB; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Chen WY; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
  • Caan BJ; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Obesity (Silver Spring) ; 27(6): 997-1004, 2019 06.
Article em En | MEDLINE | ID: mdl-31021535
ABSTRACT

OBJECTIVE:

Previous studies of breast cancer survival have not considered specific depots of adipose tissue such as subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT).

METHODS:

This study assessed these relationships among 3,235 women with stage II and III breast cancer diagnosed between 2005 and 2013 at Kaiser Permanente Northern California and between 2000 and 2012 at Dana Farber Cancer Institute. SAT and VAT areas (in centimeters squared) were calculated from routine computed tomography scans within 6 (median 1.2) months of diagnosis, covariates were collected from electronic health records, and vital status was assessed by death records. Hazard ratios (HRs) and 95% CIs were estimated using Cox regression.

RESULTS:

SAT and VAT ranged from 19.0 to 891 cm2 and from 0.484 to 454 cm2 , respectively. SAT was related to increased risk of death (127-cm2 increase; HR [95% CI] 1.13 [1.02-1.26]), but no relationship was found with VAT (78.18-cm2 increase; HR [95% CI] 1.02 [0.91-1.14]). An association with VAT was noted among women with stage II cancer (stage II HR 1.17 [95% CI 0.99-1.39]; stage III HR 0.90 [95% CI 0.76-1.07]; P interaction < 0.01). Joint increases in SAT and VAT were associated with mortality above either alone (simultaneous 1-SD increase HR 1.19 [95% CI 1.05-1.34]).

CONCLUSIONS:

SAT may be an underappreciated risk factor for breast cancer-related death.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Gordura Intra-Abdominal / Gordura Subcutânea Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Gordura Intra-Abdominal / Gordura Subcutânea Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article